In the present study, we put forward that SPRY4 could be a key mediator for the observed differences in the phenotypes of T235 (BRAF mutant) and C3948 (BRAF wild type) cell lines, under macrophage modulation in the tumor microenvironment. Here, SPRY4 is linked to neoplasm.